Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Christiana Care Health Services
With
The Cardeza Foundation for Hematologic Research
Thrombocytopenia is a common entity in infants who are born to mothers with preeclampsia and in infants who are small for gestational age. There have been several theories to the mechanism underlying thrombocytopenia in these groups of patients. One mechanism suggests that thrombocytopenia in these populations may be secondary to underproduction of platelets. Other studies have implied that low platelet levels may be due to endothelial activation causing platelet consumption. This study is being performed to help determine the mechanism causing thrombocytopenia in infants born to mothers with preeclampsia and comparing it to the mechanism of thrombocytopenia in infants who are small for gestational age.
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Infants who are less than 34 weeks gestation
Infants born to mothers with preeclampsia
Infants who are born small for gestational age whose mother did not have preeclampsia
You may not be if
Infants who are greater than 34 weeks gestation
Infants with known congenital anomalies or known congenital infections
Clareo Health | Mechanism of Thrombocytopenia in Infants
